Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lemborexant for insomnia in mild cognitive impairment or mild dementia
jRCTs071260017Recruiting
- Sponsor
- Eisai Co., Ltd.
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of lemborexant in Insomnia, sponsored by Eisai Co., Ltd. Primary endpoints: Change from baseline in total sleep time at Week 4 and Change from baseline in wake after sleep onset at Week 4. Started Jul 2026; status: recruiting.
02
Drugs
lemborexant
03
Conditions
Insomnia
Beyond the preview
Go deeper on jRCTs071260017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs071260017.